Top Markets
Coin of the day
NuGenerex Immuno-Oncology, Inc. NuGenerex Immuno-Oncology, Inc.

NuGenerex Immuno-Oncology, Inc.

NUGX
Rangering i aksjer #41797
NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating... NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating cancer through the strategic modulation of the immune system. The company's development pipeline includes a range of immunotherapeutic products and vaccines. Notably, it is advancing AE37, a peptide immunotherapeutic vaccine, which is currently undergoing Phase II clinical studies for metastatic triple-negative breast cancer. Founded in 1993 and headquartered in Miramar, Florida, the entity was formerly named Antigen Express, Inc. NuGenerex Immuno-Oncology, Inc. operates as a subsidiary of Generex Biotechnology Corporation.
Aksjekurs
$0.0001
Sist synkronisert: 2023-05-22
Markedsverdi
$10.03K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel NuGenerex Immuno-Oncology, Inc. (NUGX)

Kategori

Pris NUGX pris med markedsverdi på B
NuGenerex Immuno-Oncology, Inc. NuGenerex Immuno-Oncology, Inc.
NUGX
$0.0001
Markedsverdi av NuGenerex Immuno-Oncology, Inc.(NUGX)
Markedsverdi: $10.03K
Per August 2026 har NuGenerex Immuno-Oncology, Inc. en markedsverdi på $10.03K. Dette gjør NuGenerex Immuno-Oncology, Inc. til det 41797th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for NuGenerex Immuno-Oncology, Inc. fra 2021 til 2026
NUGX sammenlignet med topp 5 mest populære stocks
Pris på NUGX Eiendel B Markedsverdi for B Resultater
NuGenerex Immuno-Oncology, Inc. NuGenerex Immuno-Oncology, Inc.
$53,672.58 $10.03K
$5.383T +53,672,576,769.39%
NuGenerex Immuno-Oncology, Inc. NuGenerex Immuno-Oncology, Inc.
$44,101.61 $10.03K
$4.423T +44,101,607,115.73%
NuGenerex Immuno-Oncology, Inc. NuGenerex Immuno-Oncology, Inc.
$41,479.26 $10.03K
$4.160T +41,479,256,122.15%
NuGenerex Immuno-Oncology, Inc. NuGenerex Immuno-Oncology, Inc.
$36,523.64 $10.03K
$3.663T +36,523,637,357.63%
NuGenerex Immuno-Oncology, Inc. NuGenerex Immuno-Oncology, Inc.
$28,825.81 $10.03K
$2.891T +28,825,810,422.43%